Top 3 ASX Penny Stocks With Market Caps Over A$80M

The Australian market is navigating mixed signals, with a weaker overnight session in the US impacting technology stocks and growth-sensitive sectors, while energy and mining stocks may find support from stabilizing commodity prices. In such a climate, investors often look to penny stocks for their potential to offer both value and growth opportunities that larger companies might miss. Despite being an older term, penny stocks remain relevant as they can provide affordable entry points into promising sectors when backed by strong financials.

Underneath we present a selection of stocks filtered out by our screen.

Australian Vanadium (ASX:AVL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Australian Vanadium Limited, with a market cap of A$88.27 million, engages in mineral exploration activities in Australia through its subsidiary.

Operations: Australian Vanadium Limited does not report any specific revenue segments.

Market Cap: A$88.27M

Australian Vanadium Limited, with a market cap of A$88.27 million, is pre-revenue and faces challenges as highlighted by its recent earnings report showing a net loss of A$9.49 million for the year ended June 30, 2026. Despite having more cash than debt and short-term assets exceeding liabilities, the company's auditor expressed doubts about its ability to continue as a going concern. The management team is experienced with an average tenure of 3.6 years, but the departure of CFO Tom Plant adds uncertainty to its financial stability. Earnings are forecasted to grow significantly at over 46% annually.

• Take a closer look at Australian Vanadium's potential here in our financial health report.
• Learn about Australian Vanadium's future growth trajectory here.

Harvey Norman Holdings (ASX:HVN)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Harvey Norman Holdings Limited operates in the integrated retail, franchise, property, and digital system sectors with a market cap of approximately A$5.16 billion.

Operations: The company generates revenue from various segments, including A$776.94 million from its retail operations in Ireland, A$951.94 million in New Zealand, A$52.25 million in the United Kingdom, A$259.89 million across Slovenia and Croatia, A$787.24 million in Singapore and Malaysia, and A$231.55 million from non-franchised retail activities.

Market Cap: A$5.16B

Harvey Norman Holdings Limited, with a market cap of A$5.16 billion, operates across multiple international markets, generating significant revenue from regions like New Zealand (A$951.94 million) and Singapore/Malaysia (A$787.24 million). Despite a stable weekly volatility of 3%, the company's earnings have declined by 13.5% annually over five years but showed slight improvement last year with a 2% growth. The Return on Equity remains low at 10.9%, and earnings are forecasted to decline by 0.2% per year over the next three years. Recently, it faced legal challenges resulting in a A$35 million penalty impacting its financials for FY2026.

• Click here to discover the nuances of Harvey Norman Holdings with our detailed analytical financial health report.
• Evaluate Harvey Norman Holdings' prospects by accessing our earnings growth report.

Omni Bridgeway (ASX:OBL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Omni Bridgeway Limited, with a market cap of A$425.77 million, offers dispute and litigation finance services across various regions including Australia, the United States, Canada, Latin America, Asia, New Zealand, Europe, the Middle East, and Africa.

Operations: The company generates revenue of A$112.26 million from funding and providing services related to legal dispute resolution.

Market Cap: A$425.77M

Omni Bridgeway Limited, with a market cap of A$425.77 million, reported a significant decline in earnings growth (-84.6%) over the past year, despite generating revenue of A$182.24 million for the fiscal year ending June 30, 2026. Its Price-to-Earnings ratio (7.9x) is below the Australian market average, suggesting potential undervaluation; however, interest payments on its debt are not well covered by EBIT (2.3x coverage). The company has reduced its debt to equity ratio significantly over five years and maintains more cash than total debt but faces challenges with negative operating cash flow and lower profit margins compared to last year.

• Jump into the full analysis health report here for a deeper understanding of Omni Bridgeway.
• Gain insights into Omni Bridgeway's past trends and performance with our report on the company's historical track record.

Taking Advantage

• Investigate our full lineup of 397 ASX Penny Stocks right here.
• Searching for a Fresh Perspective? Rare earth metals are the new gold rush. Find out which 36 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com